Akèy › Histiyositoz selil Langerhans › Ohio
Etid klinik pou Histiyositoz selil Langerhans nan Ohio
3 etid pou Histiyositoz selil Langerhans ap chèche patisipan nan sit nan Ohio.
Tèks ofisyèl etid la (Anglè)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Rainbow Babies and Childrens Hospital, Cleveland
- Nationwide Children's Hospital, Columbus
- Dayton Children's Hospital, Dayton
Ap rekriteFaz 2
180 Days – 22 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT05828069Mirdametinib in Histiocytic Disorders
- Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekriteFaz 2
Laj 2 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06153173Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Nationwide Children's Hospital, Columbus
Ap rekriteFaz 3
Jiska laj 21 · Tout sèks · Mizajou Sep 11, 2025 · NCT02670707Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.